The short version
9 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Mozobil
Plerixafor · PLERIXAFOR 24 mg/1.2mL · Injection, Solution · Subcutaneous · Sanofi-Aventis U.S. LLC
NDC 00024-5862-01 · 1 VIAL, SINGLE-USE in 1 CARTON / 1.2 mL in 1 VIAL, SINGLE-USE · NDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Medicare Part B pays (ASP+6%)$28.49per billing unit (1 MG)HCPCS J2562 · Jul 1, 2026
- Part D plans paid (avg)$862.33per dosage unitgross, before rebates — matched by drug name · 2024
- Federal ceiling (Big4)$7,349.77per package of 1.2MLSanofi Aventis U.S. LLC · Jan 1, 2026
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$9,968.07
Reported to Texas DSHS · 2026 annual filing · Genzyme Corporation
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 MG
$28.489
HCPCS J2562 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$219,274
12 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Aptuit (Oxford) LtdUnited Kingdomanalysis · api manufacture
- Patheon Manufacturing Services LLCUnited Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $3,270.74 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA022311
- TE code
- AP
- Approval date
- Dec 15, 2008
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)Mar 13, 2026
Recalls (this NDC)
- Class III · TerminatedSep 1, 2016Sanofi-Aventis U.S. LLC — Labeling: Incorrect or Missing Package Insert
- Class III · TerminatedAug 4, 2016Genzyme Corporation / Genzyme Biosurgery — Labeling: Incorrect or Missing Lot and/or Exp. Date
Manufacturers of Plerixafor (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi Usa, LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Novadoz Pharmaceuticals LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Manufacturing Services LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | PLERIXAFOR 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sanofi-Aventis U.S. LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Mozobil — NDC 00024-5862-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00024586201.
Free to cite with attribution — see how the data is put together.